Carvedilol Tablet, Film Coated
Product Images NDC 51655-397

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 51655-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 397 26 Master Bottle Label Approval Rev A 07 20)

Carvedilol Tablets USP 25 mg film-coated tablets package label. Contains 90 tablets for oral use. Label indicates prescription-only status and storage instructions between 20°-25°C (68°-77°F). Manufactured by Northwind Health Company, LLC. NDC 51655-397-26. Additional warnings include keeping out of reach of children and protection from moisture.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of carvedilol showing its molecular arrangement with multiple aromatic rings and functional groups as represented in the diagram.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph depicting % mortality over a 24-month period for two groups: one receiving Carvedilol and the other receiving a placebo. The graph shows the mortality rate over time for both groups, with a statistical p-value of 0.0014 indicating a significant difference between Carvedilol and placebo.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot showing hazard ratios with 95% confidence intervals for various patient subgroups, such as gender, age groups, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. The x-axis represents the hazard ratio scale from 0.0 to 2.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph showing percent mortality over a 24-month period comparing placebo and carvedilol treatments. The x-axis represents months, and the y-axis represents percent mortality. The graph indicates lower mortality for carvedilol versus placebo, with a p-value of 0.03 noted.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart depicting hazard ratios with confidence intervals for various patient subgroups. The variables include age, sex, timing of randomization post-myocardial infarction, prior use of IV oral beta blockers, Killip class, thrombolytic therapy, percutaneous transluminal coronary angioplasty (PTCA), heart failure status, diuretic use, angina presence, hypertension, diabetes, heart rate, systolic blood pressure, and an overall analysis for all patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.